Sending Office: Honorable Tulsi Gabbard
Remove Marijuana from the Controlled Substances Act:
Support the bipartisan Ending Federal Marijuana Prohibition Act of 2019
Organizational Support: NORML, the National Cannabis Industry Association (NCIA), Minority Cannabis Business Association (MCBA), Drug Policy Alliance, Students for Sensible Drug Policy, Americans for Safe Access, and the Veterans Cannabis
116th Cosponsors: Gabbard, Young, Blumenauer, Soto, Holmes Norton, Schakowsky, Cohen, Carbajal, Gaetz, Amash, Pingree, Barbara Lee, Pocan, Swalwell, Khanna, Gallego, Correa, Luria, Adam Smith, DeFazio, McNerney, Neguse, Quigley, Eshoo, Max
Rose, Moulton, Evans, McGovern, McCollum, Jeffries, Raskin
Even though 33 states have legalized medical marijuana, 10 states and D.C. have legalized adult-use marijuana, and 68 percent of Americans support legalization, marijuana is still listed under Schedule 1 of the Controlled Substances Act. Enforcing federal
prohibition of marijuana will only serve to increase incarcerations, prevent invaluable research into its medicinal benefits, and create financial barriers for businesses.
We invite you to cosponsor the Ending Federal Marijuana Prohibition Act of 2019. This legislation removes marijuana from Schedule 1 and eliminates criminal penalties for individuals who grow, buy, or use marijuana in states that have chosen
to legalize and regulate a consumer marketplace. The majority of states already support decriminalization and have implemented either a regulated medical or adult-use marketplace, thus it is imperative and timely that we pass this legislation.
This bill would achieve the following:
- Allow states to make independent choices as they pertain to marijuana laws;
- Permit federally insured banks and credit institutions to provide basic banking services to the existing and future legal businesses without risk of federal intervention;
- Reduce the War on Drugs’ $51 billion annual cost to taxpayers;
- Protect the rights of 73 million Americans living in states that have legalized adult-use marijuana;
- Protect the rights of the Americans living in the 33 states that have passed a medical-marijuana program;
- Permit medical use and innovation in the marijuana industry to achieve healthcare goals, including pain management, opioid addiction therapy, treatment for seizures and those with epilepsy, cancer treatment, treatment for depression, anxiety, eating disorders,
ALS, and PTSD, among others; and
- Prevent the Department of Justice from trampling on state sovereignty and creating uncertainty in state-legalized marijuana programs.
The Ending Federal Marijuana Prohibition Act of 2019 is our opportunity to remove marijuana from the federal Controlled Substances list and allow our states the freedom to regulate marijuana as they choose without federal inference.
We welcome your support in cosponsoring this legislation and urging House leadership to bring it to the floor for a vote. If you have any questions or if you would like to sign on, please contact Patrick Koetzle (Patrick.email@example.com) with
Rep. Gabbard’s office or Jesse von Stein (firstname.lastname@example.org) with Rep. Young’s Office.
e-Dear Colleague version 2.0